Search
+
    SEARCHED FOR:

    TITAN BIOTECH LTD Q2 RESULTS

    Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunity

    Ajanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 equity shares, constituting 8.34% of the company's aggregate equity. Amidst strong financials, the company reported a 66% YoY growth in PAT and a 20% YoY increase in revenue in its Q4 results.

    Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday

    181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.

    IT & banking titans fuel 677-point Sensex rally in last leg of volatile session

    The benchmark equity indices tossed between ups and downs throughout the day and finally settled in the green. US rate -sensitive IT stocks contributed majorly to the fag-end rally as all 10 constituents advanced, adding between 1% and 4.2%. Investors gained Rs 3.1 lakh crore on Thursday.

    SBI, Godrej Consumer top buys post Q4 results; could give 13-17% upside in 1 year

    SBI and Godrej Consumer are top buys post Q4 results, led by BFSI and Auto sectors. Nifty stocks show growth, while Tier-1 IT companies face challenges. Business and credit growth outlook positive for SBI.

    Piramal Pharma shares soar 11%, hit 52-week high after Q4 profit jumps 102% YoY

    The company's revenue from operations increased by 18% to Rs 2,552.4 crore as against Rs 2,163.6 crore in the corresponding period of the preceding fiscal.

    Q1 and Q2 will see close to double-digit volume growth for Britannia: Abneesh Roy

    Abneesh Roy from Nuvama Institutional Equities discusses Britannia's positive growth outlook despite local competition and tech disruption, while also reflecting on challenges faced by Titan in the jewelry segment and eyewear business.

    The Economic Times
    BACK TO TOP